An endotoxin test result reported in EU/vial is a measurement, not automatically a pass/fail verdict. Interpreting it requires an applicable product-specific limit and the inputs behind that limit.
The observed record: Janoshik report 167470 records 536.652 EU/vial for sample R30, batch FSD0706, analyzed June 6, 2026. The certificate directly names FSD as the manufacturer. That supports a narrow statement about the submitted sample, reported unit, named batch, and analysis date. It does not establish a result for other vials, batches, or future stock.
The missing interpretation: for regulated drug products, FDA describes the endotoxin limit as K/M. K varies with route, while M depends on the maximum amount per kilogram delivered during a single one-hour period. The certificate reports EU/vial but does not provide an applicable administration route or maximum-dose input for this research sample.
The defensible Paper Trail status is therefore “measurement recorded; verdict not evaluable.” That is not a pass, fail, safe, or unsafe conclusion. It means the public record does not contain the inputs required to calculate and apply a product-specific limit.
Before an evidence board displays an endotoxin pass/fail label, should it require the raw result and unit, test method, sample and batch identity, analysis date, applicable route, maximum one-hour amount, calculation, and source for every input?